《新股消息》中國中免籌劃H股上市傳獲中金協助 或成今年最大新股
中國中免(601888.SH)曾於4月下旬公布就本港上市籌備工作與中介機構商討。據路透旗下《IFR》報道,中國中免正與中金合作,計劃來港上市,消息人士指公司有望成本港今年最大新股。
據悉公司仍未決定最終售股比例,但估計有可能與其他AH股相近,將售約10%左右的股權,以公司周三(12日)時的市值計算,意味IPO規模有望達91億美元,不過一般A股公司因估值較高,來港上市時均會有折讓。報道指公司有望最快年底前來港上市,料視乎上市規模將有更多銀行參與。
中國中免去年淨利達61億元人民幣,按年升33%,公司於1984年創立,在內地、香港、澳門、台灣及柬埔寨營運逾200家免稅店。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.